Condition
Stage III Unresectable Non-Small Cell Lung Cancer
Total Trials
1
Recruiting
0
Active
1
Completed
0
Key Insights
Highlights
Treatment Research
1 treatments under study, led by Plasma Sample Collection
Related Conditions
Often studied with 4 related conditions
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 1 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Active Not Recruiting1
Clinical Trials (1)
Showing 1 of 1 trials
Showing all 1 trials
Research Network
Common Treatments
- Plasma Sample Collection1
Active Sponsors
- OncoHost Ltd.1
Top Investigators
Asklepios Klinik Gauting GmbH
Meir Medical Center
Physicians Clinic of Iowa
Roswell Park
Protean BioDiagnostics
Related Conditions
- Stage Iv Small Cell Lung Cancer1
- Stage Iv Malignant Melanoma1
- Stage Iiibd Malignant Melanoma1
- Stage Iv Nonsmall Cell Lung Cancer1